Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley
September 07, 2021 at 15:35 PM EDT
Shares of Moderna Inc. rallied toward a fifth straight gain Tuesday, after Morgan Stanley analyst Matthew Harrison added nearly $150 to his price target on an increased outlook for the biotechnology company's COVID-19 vaccine sales.
